Drug shortage
Palivizumab Injection · Swedish Orphan Biovitrum AB
FDA drug shortage · To Be Discontinued · updated Aug 13, 2025
Key facts
| Generic name | Palivizumab Injection |
|---|---|
| Company | Swedish Orphan Biovitrum AB |
| Presentation | Synagis, Injection, 100 mg/1 mL (NDC 66658-231-01) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Antiviral |
| Package NDCs | 66658-231-01 |
| First posted | Aug 13, 2025 |
| Last updated | Aug 13, 2025 |
| Discontinued | Aug 13, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: